Gait freeze in Parkinson’s linked to sleep disorders – study
Patients with Parkinson’s disease who experience freezing of gait also [...]
Study suggests Long COVID symptoms could be linked to brain injury
New evidence has suggested that some of the symptoms reported [...]
‘First-of-its-kind’ major neurotech hub announced in Milan
A major new centre in Milan will lead research into [...]
Brain injury survivor returns to Calvert Reconnections as centre celebrates 4th anniversary
Brain injury survivor John Gaimster, who opened neuro-rehabilitation centre Calvert [...]
Daily News Round Up: Wednesday, 6 March
Welcome to your daily round-up of everything happening in the world of neurorehabilitation.
Research news
Breakthrough’s specialist care team continues to grow
Case management and complex care company Breakthrough is expanding its [...]
AI models identify memory formation patterns
A group of researchers from the Spanish National Research Council [...]
HD Immune: Developing a novel therapy for Huntington’s disease
HD Immune is developing a novel monoclonal antibody therapy for Huntington’s disease patients, aiming to interfere with disease progression and delay symptom development.
Discover:
- HD Immune's aim to rid the body of mutated protein
- What animal model research has demonstrated so far
- HD Immune's fundraising plans to advance to clinical trials
Personal recovery: key to preventing long term mental illness
A team of researchers are advocating for including a broader [...]
